Transcripts Clinuvel Pharmaceuticals Limited

Actions

Marché Fermé - Australian S.E. Autres places de cotation 08:10:10 09/07/2026			Varia. 5j.	Varia. 1 janv.
10,45 ^AUD	+1,65 %		+1,85 %	-16,13 %

02/07	Clinuvel Pharmaceuticals prolonge le mandat de son directeur général Philippe Wolgen	MT
16/06	Clinuvel Pharmaceuticals avance son projet de cotation aux États-Unis avec le dépôt d'un dossier auprès de la SEC pour le Nasdaq	MT

26/02	Transcript : Clinuvel Pharmaceuticals Limited, H1 2026 Earnings Call, Feb 26, 2026
20/10/25	Transcript : Clinuvel Pharmaceuticals Limited - Shareholder/Analyst Call
28/08/25	Transcript : Clinuvel Pharmaceuticals Limited, 2025 Earnings Call, Aug 28, 2025
27/02/25	Transcript : Clinuvel Pharmaceuticals Limited, H1 2025 Earnings Call, Feb 27, 2025
23/12/24	Transcript : Clinuvel Pharmaceuticals Limited - Special Call
16/10/24	Transcript : Clinuvel Pharmaceuticals Limited - Shareholder/Analyst Call
29/08/24	Transcript : Clinuvel Pharmaceuticals Limited, 2024 Earnings Call, Aug 29, 2024
22/02/24	Transcript : Clinuvel Pharmaceuticals Limited, H1 2024 Earnings Call, Feb 22, 2024
02/10/23	Transcript : Clinuvel Pharmaceuticals Limited - Special Call
29/08/23	Transcript : Clinuvel Pharmaceuticals Limited, 2023 Earnings Call, Aug 29, 2023
30/08/22	Transcript : Clinuvel Pharmaceuticals Limited, 2022 Earnings Call, Aug 30, 2022
23/02/22	Transcript : Clinuvel Pharmaceuticals Limited, H1 2022 Earnings Call, Feb 23, 2022